API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
0
Europe
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
81
PharmaCompass offers a list of Bosutinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Bosutinib manufacturer or Bosutinib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Bosutinib manufacturer or Bosutinib supplier.
PharmaCompass also assists you with knowing the Bosutinib API Price utilized in the formulation of products. Bosutinib API Price is not always fixed or binding as the Bosutinib Price is obtained through a variety of data sources. The Bosutinib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Bosutinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bosutinib, including repackagers and relabelers. The FDA regulates Bosutinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bosutinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Bosutinib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Bosutinib supplier is an individual or a company that provides Bosutinib active pharmaceutical ingredient (API) or Bosutinib finished formulations upon request. The Bosutinib suppliers may include Bosutinib API manufacturers, exporters, distributors and traders.
click here to find a list of Bosutinib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Bosutinib DMF (Drug Master File) is a document detailing the whole manufacturing process of Bosutinib active pharmaceutical ingredient (API) in detail. Different forms of Bosutinib DMFs exist exist since differing nations have different regulations, such as Bosutinib USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Bosutinib DMF submitted to regulatory agencies in the US is known as a USDMF. Bosutinib USDMF includes data on Bosutinib's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Bosutinib USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Bosutinib suppliers with USDMF on PharmaCompass.
A Bosutinib written confirmation (Bosutinib WC) is an official document issued by a regulatory agency to a Bosutinib manufacturer, verifying that the manufacturing facility of a Bosutinib active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Bosutinib APIs or Bosutinib finished pharmaceutical products to another nation, regulatory agencies frequently require a Bosutinib WC (written confirmation) as part of the regulatory process.
click here to find a list of Bosutinib suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Bosutinib as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Bosutinib API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Bosutinib as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Bosutinib and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Bosutinib NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Bosutinib suppliers with NDC on PharmaCompass.
Bosutinib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Bosutinib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Bosutinib GMP manufacturer or Bosutinib GMP API supplier for your needs.
A Bosutinib CoA (Certificate of Analysis) is a formal document that attests to Bosutinib's compliance with Bosutinib specifications and serves as a tool for batch-level quality control.
Bosutinib CoA mostly includes findings from lab analyses of a specific batch. For each Bosutinib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Bosutinib may be tested according to a variety of international standards, such as European Pharmacopoeia (Bosutinib EP), Bosutinib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bosutinib USP).